Leadership & Pay ·
Change Agents appoints Eric Weisblum as independent director effective Oct 12
CHGAChange Agents Corporation.
Change Agents Corporation appointed Eric Weisblum as an independent director on its board of directors, effective October 12, 2026. Mr. Weisblum will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees. He is currently the CEO of Silo Pharma Inc., a biopharmaceutical company he founded in 2020, and brings decades of experience in investment banking, capital markets, and public company management. The appointment was announced via an 8-K filing on October 14, 2026. Change Agents Corporation operates as a financial services firm providing corporate finance advisory and investment banking services.